NCT05493735View on ClinicalTrials.gov

Lidocaine for Pessary Check Pain Reduction

PHASE3CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

September 8, 2022

Primary Completion Date

June 23, 2023

Study Completion Date

June 30, 2023

Conditions
Pelvic Organ ProlapseStress Urinary Incontinence
Interventions
DRUG

Lidocaine Hcl 2% Jelly

Participants in the experimental arm will undergo pessary removal and reinsertion after the application of lidocaine topical gel.

DRUG

Placebo Jelly

Participants in the control arm will undergo pessary removal and reinsertion after the application of lubricating jelly.

Trial Locations (1)

33606

USF Health Outpatient Urogynecology Clinics, Tampa

All Listed Sponsors
lead

University of South Florida

OTHER